Tell us about your exciting accomplishments!

OVPR staff is excited about the breakthroughs in research and scholarly accomplishments on our campus. If you have been awarded a grant, submitted a paper for publication or been notified that your research is being published in a scholarly journal, please contact us at so we can share the news with the rest of the OUHSC research community.

"The ORA submission process: A review for new investigators"
New PI Training 04-20-16 Final

Other helpful information

On this page, you will also find useful Institutional Data that you may be asked to provide when submitting a proposal.   Please let us know if there is additional information or links you would like to see on our site. Simply complete our Suggestion Form.

ORA Research News - Monday, August 5, 2019

ORA Research News - Monday, August 5, 2019



DEADLINE UPDATE: IBEST-OUHSC Funding for Interdisciplinary Research – Request for Applications to

support collaborative research activities between OUHSC researchers and OU-Norman researchers in the area of

biomedical engineering - Deadline September 6, 2019 – please see guidelines and face page attached. page_final.pdf?ver=2019-07-01-074315-193


COGR and the Health Research Alliance (HRA) invite you to save-the-date on September 24, 2019 for a day-long

workshop of the Nonprofit Funder – Research Institution (NFRI) Partnership.  The workshop will facilitate

ongoing discussions and efforts around four key elements of foundation-institution relations: (1) Streamlining

administrative requirements; (2) Indirect costs/research project support costs; (3) Intellectual property and tech transfer

issues; and (4) overall principles for successful partnerships between nonprofit funders and research institutions. This

is the fourth in-person NFRI partnership meeting. Additional information on the history of the partnership and presentations

and materials from previous meetings can be found at

The draft agenda for the September 24 meeting can be found at the website above and registration will be opening soon.

The location of the workshop is the American Association for the Advancement of Science (AAAS) Building, located at

1200 New York Ave, Washington, DC 20005 (also home to COGR). AAAS headquarters are one block from the

Washington metro’s Metro Center station, which services the red, orange, blue and silver lines, and a 10-15 minute walk

from Gallery Place (serving the yellow and green metro lines).  It’s recommended that you make your hotel reservations

early as this area books up quickly. 



NIH issued a notice yesterday delaying the requirement for institutions to report the results of basic research on human

studies in until September 2021.  The delay applies only to basic experimental studies with humans

(BESH) studies submitted to funding opportunities designated as “basic experimental studies with humans” in the title. 

Applicants must identify alternative platforms for reporting the research results and include the information in the

Dissemination Plan attachment of the application.

In a November 2018 letter, COGR, many other organizations, and many of our member institutions strongly urged the

NIH to separate the reporting of clinical trial studies from basic research and consider a more appropriate reporting

mechanism for basic research studies.

See the full notice at

Contact Information:      Michelle D. Christy
Council on Governmental Relations
1200 New York Ave NW Suite 460
Washington DC 20005
Cell: 617-223-1551



Executive Order 13861 (

the President’s Roadmap to Empower Veterans and End a National Tragedy of Suicide (PREVENTS) was

signed March 5, 2019. VA is pleased that this EO effort is led by an inter-agency Cabinet-level Task Force and Dr. Barbara

Van Dahlen as the Executive Director. The goal of the Task Force is to create a Roadmap that will reduce suicide by

empowering veterans to pursue an improved quality of life, prioritizing research, and establishing collaboration across the

public and private sectors.  The Roadmap will utilize a public health approach with the goal of changing the culture of how

veteran suicide is approached, discussed and prevented. It will be a comprehensive plan building on existing efforts from each

agency and office that is represented on the Task Force. It also intends to reach out across all communities collaborating

under this EO.  For additional information see the attached document.



Bridge Grant Program – DUE DATE AUGUST 16, 2019 (REVISED GUIDELINES)

The primary objective of the PHF Bridge Grant program is to provide funding to enhance OUHSC faculty competitiveness for

extramural funding.  OUHSC Principal Investigators who have submitted an extramural application that was scored but not

funded within the past 18 months and is requesting over $750,000 in total direct costs and over $200,000 in total facilities and

administration (F&A) costs and received a review that ranks applications and provides critiques are eligible.  This program can

provide funding for up to $75,000 for one year.  Guidelines and Application Form is attached or can be found at: Grant Guidelines - August 16 2019.docx?ver=2019-07-16-080651-860 Projects in Diabetes CoBRE flyer 2019.pdf?ver=2019-07-22-082134-707


The Diabetes CoBRE Program at OUHSC intends to support pilot projects. The goal is to provide seed funds to

support projects that have the potential to receive NIH funding in the future. Any investigator working in the state of Oklahoma

who meets the requirements defined below, and who has a project related to diabetes or diabetic complications, is welcome to

apply.  The application deadline is 5pm, August 16, 2019.   Funding starts by October 1, 2019. 

See the attached document and go to: Projects in Diabetes CoBRE flyer 2019.pdf?ver=2019-07-22-082134-707


The Oklahoma Clinical and Translational Science Institute (OCTSI) and Oklahoma Shared Clinical and Translational Resources

(OSCTR) is soliciting applications for its Clinical and Translational Research Pilot (CTRP) Grants Program and its Community

Engaged Research Exploratory Awards.

Oklahoma Shared Clinical and Translational Resources Clinical and Translational Research Pilot (CTRP) Grants

The purpose of the program is to provide funding for collaborative and/or multi-disciplinary clinical and translational pilot projects

between investigators of the OSCTR member institutions. The program seeks to support proposals designed to generate preliminary

data that will result in improved health and/or healthcare for citizens of Oklahoma and other IDeA states and enhance the

competitiveness of the investigators for future extramural funding. The program also seeks to fund innovative concepts, approaches,

and methodologies that bring fresh new ideas to solving the health issues of those living in Oklahoma and collaborating IDeA states.

Projects that focus on the medically underserved and on health concerns prevalent within Oklahoma and our OSCTR partners will

be a priority. Only projects which meet the NIH definition of clinical and/or translational research will be accepted.

Approved CTRP grants will be funded for a period starting January 1, 2020 contingent on NIH approval of just in time (JIT) information.

All funds are required to be expended by December 31, 2020.

The forms, instructions, and submission link can be found at:

Deadlines for submission:   Pilot Proposal – Friday, August 9, 2019 at 5:00 PM CDT


Oklahoma Shared Clinical and Translational Resources Community-Engaged Research Exploratory (CERE) Awards

This program is intended to support community engagement to develop funded research partnerships. Funds can be used for research

development activities, including convening partners, working with individuals pursuing related work, and conducting needs assessments

in community settings. The funds cannot be used to support actual human-subjects research protocols, which can be funded under other

OSCTR pilot research programs and/or external funding.

The application should consist of a 2-page letter from the main applicant (which can be either a community agency or an academic

researcher) describing the collaboration, the contributions that the proposed work will make to a successful research partnership, and a

line item budget. Budget requests are expected to be $5,000-$10,000 with budgets that permit the expenditure of the entire award by

June 30, 2020. A separate letter of support from either the academic or community partner indicating their agreement with the proposed

activities should also be included. Proposals will be evaluated on a rolling basis beginning July 1, 2019. Please submit proposals by

email to

Interested applicants can discuss their proposal, eligibility, allowable budget items, and available funding by contacting the OSCTR

staff at or call 405-271-3480.


OSCTR TPIR Trainee Program

Seeking applicants for the sixth year of the research training program Translating Practice into

Research (TPIR). TPIR is a program for healthcare professionals, clinical investigators, and basic

Scientists and it is funded by the NIH Oklahoma Shared Clinical and Translational Resources grant. The goal

of the TPIR trainee program is to produce a group of clinicians and scientists who have the ability to

translate their clinical observations and ideas for improving practice into practical and feasible research

projects. Attached is a detailed description and application due September 3, 2019. CERE Instructions 2019.pdf?ver=2019-07-01-074315-177


Harold Hamm Diabetes Center (HHDC) - Please mark your calendar for the 16th Annual Harold Hamm

Diabetes Center Research Symposium.  This event will be held on Friday, November 15, 2019 at the Samis Education Center at

Children’s Hospital in Oklahoma City. Deadline for abstracts will be announced later this summer.  Additional details will be posted on  Questions?  Please email





Extension of Certain Flexibilities for Prospective Basic Experimental Studies With Human Participants


Changes to NIH Requirements Regarding Proposed Human Fetal Tissue Research (NOT-OD-19-128)


Notice of Informational Webinar for PAR-19-301 Limited Competition: NIGMS National and Regional Resources

(R24 Clinical Trial Not Allowed) (NOT-GM-19-053)


Consolidated Notice on NIMH Clinical Trials Policies (NOT-MH-19-031)


Registration Open for the ICARE Academy on September 10-11, 2019, in Alexandria, VA (NOT-OD-19-123)


Notice of System Change and Procedure for Requesting an Extension to Early Stage Investigator (ESI)

Status (NOT-OD-19-125)


Request for Information (RFI): Swallowable Smart Pills or Devices to Enable Precision Nutrition, Microbiome and

Gastroenterological Research (NOT-DK-19-020)


Notice of Correction to PAR-19-314 "NIA Program Project Applications (P01 Clinical Trial Optional)"


Notice of Clarification to PAR-18-841, "Oncology Co-Clinical Imaging Research Resources to Encourage Consensus

on Quantitative Imaging Methods and Precision Medicine (U24 - Clinical Trial Optional)"


Notice of Clarification of Program Director/Principal Investigator Eligibility for PAR-19-102 Graduate Research

Training Initiative for Student Enhancement (G-RISE) (T32) (NOT-GM-19-050)


Notice of Clarification of Program Director/Principal Investigator Eligibility for PAR-19-218 Undergraduate Research

Training Initiative for Student Enhancement (U-RISE) (T34) (NOT-GM-19-051)


Notice of Clarification of Eligibility for PAR-19-286 "Postdoctoral Research Associate Training (PRAT) Program (Fi2)



Notice of Intent to Publish the Reissuance of RFA-CA-18-026, "Improving the Reach and Quality of Cancer Care in

Rural Populations (R01 Clinical Trial Required)" (NOT-CA-19-063)



Please Note:  When only one application is allowed per Institution according to the sponsor

instructions, a one-page letter of intent summarizing the proposed project should be submitted

to the Vice President for Research at least one month prior to the application deadline (unless

otherwise noted).  The letters of intent will be reviewed and a single application will be chosen  

for submission from the University.




Strategic Alliances for Medications Development to Treat Substance Use Disorders (R01-Clinical Trial Optional)

(PAR-19-318) – Deadline on rolling basis starting August 26, 2019


Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Independent Clinical Trial Not Allowed)

(RFA-AG-20-010) - October 22, 2019


Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Clinical Trial Required)
(RFA-AG-20-011) - Deadline October 22, 2019

Microbiome and Aging: Impact on Health and Disease (R01 Clinical Trial Not Allowed) (RFA-AG-20-030)
Deadline October 30, 2019


Preclinical Screening for Natural Product Drug Interactions (Clinical Trial Not Allowed, R21)
(RFA-AT-20-001) – Deadline November 01, 2019


Center of Excellence for Natural Product Drug interaction Research (U54, Clinical Trial Required)
(RFA-AT-20-002) – Deadline November 22, 2019


(Re)Building a Kidney (UC2 Clinical Trial Not Allowed) (RFA-DK-19-007) – Deadline November 7, 2019


Polycystic Kidney Disease Research and Translation Core Centers (U54 Clinical Trial Not Allowed)
(RFA-DK-19-010) - Deadline November 21, 2019


Central Coordinating Site for the Polycystic Kidney Disease Research and Translation Core Centers

(U24 Clinical Trial Not Allowed) (RFA-DK-19-011) – Deadline November 21, 2019





National Science Foundation (NSF) - Graduate Research Fellowship Program (GRFP)

Different types of fellowships with their own individual deadlines





BrightFocus Foundation – National Glaucoma Research – Deadline November 8, 2019


The Dickson Prize in Medicine – Deadline October 4, 2019